Agendia announces study showing molecular subtyping can improve breast cancer treatme

[News]

In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular...

More... (http://www.medicalnewstoday.com/releases/282001.php)